Countdown to 2024 Summer Olympics: Lilly, U.S. Gymnast Suni Lee Shine Spotlight on Life With Eczema July 18, 2024
FDA Approves Arcutis’ Roflumilast Cream 0.15% for the Treatment of AD in Adults and Children Down to Age 6 July 9, 2024
From the Podium to Your Practice: Dr. Jonathan Silverberg Reviews New Data Showing That Upadacitinib Beat Dupilumab Across All Ranked Secondary End Points in Head-to-head AD Trial June 14, 2024
